TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 20, No. 6 March 18, 2014
__________________________________________________________
UPCOMING MEETINGS EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 20, No. 6 March 18, 2014
(The next issue will be on April 1, 2014)
TRIGGER is also available by RSS Feed:
and BLOG:
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm
ISTH also maintains a list of upcoming meetings of
interest:
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
(2013) [Lung
tissue factor expression changes in relation to the stage of respiratory
distress syndrome in the presence of pneumonia in A/H1N1 influenza]. Arkh Patol
75:16-21.
Acquazzino MA, Rush ET, Quiros Tejeira RE, Beck JC (2014)
Liver transplant for congenital factor VII deficiency. Pediatr Blood Cancer.
Brandt KJ, Fickentscher C, Boehlen F, Kruithof EK, de
Moerloose P (2014) NF-B is Activated from Endosomal Compartments in
Antiphospholipid Antibodies-treated Human Monocytes. J Thromb Haemost.
Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E,
Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors
in blood from patients with atherosclerotic vascular disease. Coron Artery Dis
24:468-474.
Buxhofer-Ausch V, Olcaydu D, Gisslinger B, Schalling M,
Frantal S, Thiele J, . . . Gisslinger H (2014) Decanucleotide insertion
polymorphism of F7 significantly influences the risk of thrombosis in patients
with essential thrombocythemia. Eur J Haematol.
Cate HT, Meade T (2014) The Northwick Park Heart Study:
Evidence from the Laboratory. J Thromb Haemost.
Choi Q, Kim JE, Hyun J, Han KS, Kim HK (2013)
Contributions of procoagulants and anticoagulants to the international
normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful
determinant of coagulation assays. Thromb Res 132:e70-75.
D'Asti E, Magnus N, Meehan B, Garnier D, Rak J (2014)
Genetic Basis of Thrombosis in Cancer. Semin Thromb Hemost.
De Robertis E, Kozek-Langenecker S, Tufano R, Romano GM,
Piazza O, Zito Marinosci G (2014) Coagulopathy induced by acidosis, hypothermia
and hypocalcaemia in severe bleeding. Minerva Anestesiol.
Ding Q, Shen Y, Yang L, Wang X, Rezaie AR (2013) The
missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient
causes molecular defect in the clotting cascade. Thromb Haemost 110:53-61.
E Y, He N, Fan H (2013) The effect of short-term
intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local
thrombotic environment after angioplasty. Cardiovasc Intervent Radiol
36:1086-1096.
Francischetti IM, Gordon E, Bizzarro B, Gera N, Andrade
BB, Oliveira F, . . . Waisberg M (2014) Tempol, an intracellular antioxidant,
inhibits tissue factor expression, attenuates dendritic cell function, and is
partially protective in a murine model of cerebral malaria. PLoS One 9:e87140.
Fujii T, Saito S (2014) Hemostatic treatment for intractable
traumatic hemorrhage using fibrinogen concentrates and recombinant activated
factor VII. Rinsho Ketsueki 55:234-238.
Gleizes C, Constantinescu A, Abbas M, Zobairi F, Kessler
L, Toti F (2014) Liraglutide protects Rin-m5f beta cells by
reducing procoagulant tissue factor activity and apoptosis prompted by
microparticles under conditions mimicking Instant Blood Mediated Inflammatory
Reaction. Transpl Int.
Gomes M, Khorana AA (2014) Risk Assessment for Thrombosis
in Cancer. Semin Thromb Hemost.
Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD,
Leong T, Tanaka KA (2014) Augmentation of thrombin generation in neonates
undergoing cardiopulmonary bypass. Br J Anaesth 112:319-327.
Henn LW, Esmailian F (2013) Repair of a large main
pulmonary artery aneurysm in a 71-year-old Jehovah's Witness patient. Tex Heart
Inst J 40:350-352.
Htun KT, McFadyen J, Tran HA (2014) The successful
management of dabigatran-associated critical end-organ bleeding with
recombinant factor VIIa. Ann Hematol.
Jo JT, Schiff D, Perry JR (2014) Thrombosis in Brain
Tumors. Semin Thromb Hemost.
Kuroda H, Ishikawa K, Jomen W, Yoshida M, Yamada M, Abe
T, . . . Kato J (2013) [Primary myelofibrosis complicated by acquired hemophilia
A and subsequent development of acute myeloid leukemia]. Rinsho Ketsueki
54:2192-2198.
Kwaan HC (2014) The Unique Hemostatic Dysfunction in
Acute Promyelocytic Leukemia. Semin Thromb Hemost.
Larcombe PJ, Kapur N, Fraser CJ, Coulthard MG, Schlapbach
LJ (2014) Intrabronchial administration of activated recombinant factor VII in
a young child with diffuse alveolar hemorrhage. Pediatr Blood Cancer
61:570-571.
Leers MP, Keuren JF, Frissen ME, Huts M, Kragten JA, Jie
KS (2013) The pro- and anticoagulant role of blood-borne phagocytes in patients
with acute coronary syndrome. Thromb Haemost 110:101-109.
Liu Q, Xu B, Xiao T, Su J, Zhong L (2013) Molecular
cloning, characterization and expression analysis of coagulation factor VII
gene in grass carp (Ctenopharyngodon idella). Fish Shellfish Immunol
35:618-622.
Mackman N, Luther T (2013) Platelet tissue factor: to be
or not to be. Thromb Res 132:3-5.
Maier MA, Jayaraman M, Matsuda S, Liu J, Barros S,
Querbes W, . . . Akinc A (2013) Biodegradable lipids enabling rapidly
eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol
Ther 21:1570-1578.
Mazzeffi M, Szlam F, Jakubowski JA, Tanaka KA, Sugidachi
A, Levy JH (2013) In vitro effects of recombinant activated factor
VII on thrombin generation and coagulation following inhibition of platelet
procoagulant activity by prasugrel. Thromb Res 132:106-111.
Omran N, Harrer J, Brtko M, Habal P, Turek Z, Pojar M,
Brozik J (2013) Recombinant activated factor VII administration
after pulmonary embolectomy: case report. Heart Surg Forum 16:E205-207.
Osterud B, Olsen JO (2013) Human platelets do not express
tissue factor. Thromb Res 132:112-115.
Pamuk BO, Sari I, Selcuk S, Gokce G, Kozaci DL (2013)
Evaluation of circulating endothelial biomarkers in familial Mediterranean
fever.
Rheumatol Int 33:1967-1972.
Perzborn E, Gruber A, Tinel H, Marzec UM, Buetehorn U,
Buchmueller A, . . . Laux V (2013) Reversal of rivaroxaban anticoagulation by
haemostatic agents in rats and primates. Thromb Haemost 110:162-172.
Raja O, Imane S, Saadia F, Bouchra O (2013) [Lack of
congenital factor VII]. Tunis Med 91:482-483.
Sbrana F, Coceani M, Panchetti L, Pasanisi EM, Rovai D,
Del Corso A (2013) Factor VII deficiency, masked by warfarin therapy,
as a cause of bleeding after cardiovascular intervention. Cardiovasc Intervent
Radiol 36:1180-1183.
Shetty S, Shelar T, Mirgal D, Nawadkar V, Pinto P,
Shabhag S, . . . Ghosh K (2014) Rare coagulation factor deficiencies: a
countrywide screening data from India. Haemophilia.
Siboni SM, Biguzzi E, Pasta G, Mannucci PM, Mistretta C,
Fantini NN, . . . Peyvandi F (2014) Management of orthopaedic surgery in rare
bleeding disorders. Haemophilia.
Singh SP, Chauhan S, Choudhury M, Malik V, Choudhary SK
(2014) Recombinant activated factor VII in cardiac surgery: single-center
experience. Asian Cardiovasc Thorac Ann 22:148-154.
Stein P, Bosshart M, Brand B, Schlicker A, Spahn DR,
Bettex D (2014) Dabigatran anticoagulation and Stanford type A aortic
dissection: lethal coincidence: Case report with literature review.
Acta Anaesthesiol Scand.
Sugita C, Yamashita A, Matsuura Y, Iwakiri T, Okuyama N,
Matsuda S, . . . Asada Y (2013) Elevated plasma factor VIII enhances
venous thrombus formation in rabbits: contribution of factor XI, von Willebrand
factor and tissue factor. Thromb Haemost 110:62-75.
van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom
BA, van Kraaij MG, Masereeuw R, . . . van Heerde WL (2013) Pharmacodynamics of
recombinant activated factor VII and plasma-derived factor VII in a cohort of
severe FVII deficient patients. Thromb Res 132:116-122.
Wang Z, Li J, Cao L, Yu Z, Bai X, Ruan C (2014)
[Hypofibrinogenemia caused by long-term administration of hemocoagulase: three
cases report and literature review]. Zhonghua Xue Ye Xue Za Zhi 35:50-52.
Wood JP, Ellery PE, Maroney SA, Mast AE (2014) Biology of
tissue factor pathway inhibitor. Blood.
Xie H, Sheng L, Zhou H, Yan J (2014) The role of TLR4 in
pathophysiology of antiphospholipid syndrome-associated thrombosis and
pregnancy morbidity. Br J Haematol 164:165-176.
Zhang X, McGeoch SC, Megson IL, Macrury SM, Johnstone AM,
Abraham P, . . . Lobley GE (2014) Oat-enriched diet reduces inflammatory status
assessed by circulating cell-derived microparticle concentrations in type 2
diabetes. Mol Nutr Food Res.
Zhu B, Zhang P, Zeng P, Huang Z, Dong TF, Gui YK, Zhang
GW (2013) Tissue factor pathway inhibitor-2 silencing promotes hepatocellular
carcinoma cell invasion in vitro. Anat Rec (Hoboken) 296:1708-1716.
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
